CN Patent

CN109912599A — 化学实体、组合物和方法

Assigned to Intellikine LLC · Expires 2019-06-21 · 7y expired

What this patent protects

本申请描述了调节PI3激酶活性的化学实体、包含所述化学实体的药物组合物以及使用这些化学实体来治疗与PO激酶活性相关的疾病和病状的方法。

USPTO Abstract

本申请描述了调节PI3激酶活性的化学实体、包含所述化学实体的药物组合物以及使用这些化学实体来治疗与PO激酶活性相关的疾病和病状的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109912599A
Jurisdiction
CN
Classification
—
Expires
2019-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Intellikine LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.